Protein-based drug carriers are ideal drug-delivery platforms
because
of their biocompatibility, biodegradability, and low toxicity. Many
types and shapes of protein-based platforms, including nanoparticles,
hydrogels, films, and minipellets, have been prepared to deliver drug
molecules. In this study, protein films containing the desired amounts
of doxorubicin (DOX) as cancer drugs were developed using a simple
mixing method. The release ratio and rate of DOXs were dependent on
the surfactant concentration. The drug release ratio was controlled
within the range of 20–90% depending on the amount of the surfactant
used. The protein film surface was analyzed using a microscope before
and after drug release, and the relationship between the degree of
film swelling and the drug release ratio was discussed. Moreover,
the effects of cationic surfactants on the protein film were investigated.
Non-toxic conditions of the protein films were confirmed in normal
cells, while the toxicity of the drug-encapsulated protein film was
confirmed in cancer cells. Remarkably, it was observed that the drug-encapsulated
protein film could eliminate 10–70% of cancer cells, with the
extent of efficacy varying based on the surfactant amount.